✦ LIBER ✦

Target-selective cytotoxicity of methotrexate conjugated with monoclonal anti-MM46 antibody

✍ Scribed by Noriaki Endo; Yumiko Takeda; Kazuo Kishida; Yoshinori Kato; Masahiko Saito; Naoji Umemoto; Takeshi Hara

Publisher: Springer-Verlag
Year: 1987
Tongue: English
Weight: 594 KB
Volume: 25
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf00199293

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytotoxicities of two disulfide-bond-lin

Cytotoxicities of two disulfide-bond-linked conjugates of methotrexate with monoclonal anti-MM46 antibody

✍ Naoji Umemoto; Yoshinori Kato; Takeshi Hara 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 859 KB

Preparation and in vitro cytotoxicity of

Preparation and in vitro cytotoxicity of a methotrexate-anti-MM46 monoclonal antibody conjugate via an oligopeptide spacer

✍ Naoji Umemoto; Yoshinori Kato; Noriaki Endo; Yumiko Takeda; Takeshi Hara 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 829 KB

Conjugates of elliptinium acetate with m

Conjugates of elliptinium acetate with mouse monoclonal anti-α-fetoprotein antibodies or fab fragments: In vitro cytotoxic effects upon human hepatoma cell lines

✍ Gilles F. Alberici; Marc Pallardy; Luc Manil; Jean-Jacques Dessaux; Jacqueline F 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 628 KB

Radiographic, clinical, and functional o

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo-controlled, 52-week trial

✍ Edward C. Keystone; Arthur F. Kavanaugh; John T. Sharp; Hyman Tannenbaum; Ye Hua 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views

Golimumab, a human anti–tumor necrosis f

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

Erratum: Golimumab, a human anti-tumor n

Erratum: Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views